US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO

Three IPOs and five SPACs priced this week. Six IPOs and two SPACs submitted initial filings.In the first sizable deal of 2026, solid tumor biotech Aktis Oncology (AKTS) priced its upsized IPO at the high end of the range to raise $318 million at a $1.0 billion market cap. The company is a Phase 1 biotech developing alpha-emitting radiopharmaceuticals against prevalent solid tumors. Preclinical studies suggest superior efficacy vs. Padcev, but Aktis faces risk given its early-stage pipeline and lack of human data until at least 1Q27. Its pipeline features Ac-AKY-1189 for Nectin-4-expressing cancers and Ac-AKY-2519 targeting B7-H3-expressing tumors. Aktis finished the week up 24%.Texas-based juice manufacturer Buda Juice (BUDA) priced its IPO at the low end of the range to raise $20 million at a $95 million market cap. The company states that it is pioneering the "UltraFresh" juice category through its end-to-end cold chain platform. Its product portfolio consists of fresh citrus juices and wellness shots across multiple brand lines and retail customers, which it believes demonstrates both brand diversification and private label manufacturing capabilities. Buda Juice finished the week up 9%.While not included in the table below, Brazilian mineral exploration company Atlas Critical Minerals (ATCX) priced its upsized IPO at the low end of the range to raise $10 million at a $40 million market cap. The company’s portfolio includes rare earth and titanium prospects in Goiás and Minas Gerais, graphite properties in Minas Gerais, copper and nickel rights in Goiás and Piauí, and uranium-bearing areas across six states in Brazil. Atlas finished the week up 10%.Five SPACs also priced this week. Lafayette Digital Acquisition (ZKPU) raised $250 million to target financial services and tech. Bleichroeder Acquisition II (BBCQU) raised $250 million to target technology. Daniel Cohen’s Art Technology Acquisition (ARTCU) raised $220 million to target tech, art, and finance. Soren Acquisition (SORNU) also raised $220 million to target healthcare. Black Spade Acquisition (BIIIU) raised $150 million to target leisure, entertainment, and digital assets.Six IPOs submitted initial filings. Brazilan digital bank PicS (PICS) filed to raise an estimated $500 million. Budget furniture retailer Bobs Discount Furniture (BOBS) filed to raise an estimated $400 million. Electrical distribution equipment manufacturer Forgent Power Solutions (FPS) filed to raise an estimated $200 million. Hair loss biotech Veradermics (MANE) filed to raise $100 million. Oncology biotech Eikon Therapeutics (EIKN) filed to raise $100 million. Drug-resistant infection treatment developer Lakewood-Amedex Biotherapeutics (LABT) filed for a direct listing on the Nasdaq. IPO Market SnapshotThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 1/8/2026, the Renaissance IPO Index was up 3.9% year-to-date, while the S&P 500 was up 1.1%. Renaissance Capital’s IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Reddit (RDDT) and Kenvue (KVUE). The Renaissance International IPO Index was up 7.2% year-to-date, while the ACWX was up 2.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Kioxia and Galderma.